Literature DB >> 31960434

Comparison of methods to determine primary tumour size in canine apocrine gland anal sac adenocarcinoma.

A N Schlag1, T Johnson2, A Vinayak2, A Kuvaldina3, O T Skinner3, B G Wustefeld-Janssens1.   

Abstract

OBJECTIVES: To assess agreement between measurement of primary apocrine gland anal sac adenocarcinoma tumours using digital palpation, CT and formalin-fixed tissue and to look for associations with metastasis at presentation.
MATERIALS AND METHODS: Retrospective study of different methods of measuring primary tumour size in histopathologically-confirmed canine apocrine gland anal sac adenocarcinoma.
RESULTS: One hundred sixteen tumours from 107 dogs were included. There was moderate agreement between maximal dimension of the primary tumour measured by CT compared to formalin-fixed tissue and digital palpation. There was no significant difference in median maximum dimension between the measurement methods. Vascular invasion, CT stage, digital rectal examination stage and formalin-fixed tissue stage were significantly associated with metastasis at presentation, while mitotic index of the primary tumour was not. Dogs with tumours >2.5 cm (tumour-stage 2) were significantly more likely to present with metastatic disease. CLINICAL SIGNIFICANCE: In canine apocrine gland anal sac adenocarcinoma, primary tumour size, tumour-stage and vascular invasion are strong predictors of metastasis at presentation.
© 2020 British Small Animal Veterinary Association.

Entities:  

Year:  2020        PMID: 31960434     DOI: 10.1111/jsap.13104

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  1 in total

1.  Quantification of Canine Apocrine Gland Anal Sac Adenocarcinoma (AGASACA) Tumor Specimen Shrinkage after Formalin Fixation.

Authors:  Brandan G Wustefeld-Janssens; Arathi Vinayak; Lindsay A Parker; Danielle L Hollenbeck
Journal:  Animals (Basel)       Date:  2022-07-22       Impact factor: 3.231

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.